The second quarter of 2026 brought several developments in federal health IT, AI governance, interoperability, and clinical research. Here are six stories you should know about.
1. Social Security Administration joins TEFCA network
In April, Social Security Administration (SSA) joined the Trusted Exchange Framework and Common Agreement (TEFCA) through the eHealth Exchange as its Qualified Health Information Network (QHIN) to dramatically improve how it obtains medical evidence for disability claims. Early reports by SSA suggest that this interoperability could reduce claim processing times by more than 50% in many cases, allowing faster decisions for applicants.
2. FDA launches real-time clinical trial initiative
In April, the U.S. Food and Drug Administration (FDA) announced two proof-of-concept clinical trials to report safety and efficacy signals to regulators in real time rather than through traditional periodic submissions. The agency also launched a request for information (RFI) on a broader pilot program for AI-enabled clinical trial optimization. Given the challenges of early-phase clinical trials – including uncertainty, limited patient populations, and inefficient decision-making – this initiative could fully alter how clinical trials are monitored and reviewed, streamlining drug development.
3. FDA issues warning to pharma company for AI misuse
In April, the FDA issued a Warning Letter to a pharma company for relying on AI without appropriate human oversight or accountability. The letter states, “… the FDA investigators found that you had not conducted process validation prior to distribution of your drug products… you replied that you were not aware of the legal requirement, as the AI agent you used (b)(4), never told you it was required.” This letter reinforces the need for a human-in-the-loop approach in the life sciences, ensuring that AI-generated outputs are properly documented, reviewed, and validated by real people.
4. CMS establishes Office of Health Technology and Products
In June, HHS Secretary Robert F. Kennedy Jr. approved a new Office of Health Technology and Products to lead digital modernization efforts across Medicare, Medicaid, and other programs. The office will oversee interoperability, AI governance, provider and beneficiary technology platforms, and modernization of key systems such as provider directories and Medicare claims processing.
5. ONC offers $2M for modern healthcare technologies
In June, the Office of the National Coordinator for Health IT (ONC) announced a $2 million grant program to advance open-source clinical AI and interoperability through its 2026 Leading Edge Acceleration Projects (LEAP) in Health IT. The core goal of the LEAP initiative is to accelerate the adoption of standards-based agentic artificial intelligence technologies in clinical settings. The hope is that these tools will enhance diagnostic accuracy, streamline workflows, and improve patient outcomes.
6. Biotech company shares surge after FDA reversal on Huntington’s therapy
In June, uniQure announced that the FDA had indicated data from its existing Huntington’s disease gene therapy study could support an accelerated approval application, eliminating the need for an additional trial before submission. The decision marks a notable shift in the agency’s recognition of the challenges in rare disease and may signal greater regulatory flexibility for gene therapy developers. UniQure plans to submit its application in the third quarter of 2026.
